Literature DB >> 22120277

Novel animal glioma models that separately exhibit two different invasive and angiogenic phenotypes of human glioblastomas.

Satoshi Inoue1, Tomotsugu Ichikawa, Kazuhiko Kurozumi, Tomoko Maruo, Manabu Onishi, Koichi Yoshida, Kentaro Fujii, Hirokazu Kambara, E Antonio Chiocca, Isao Date.   

Abstract

OBJECTIVE: Invasive behaviors of malignant gliomas are fundamental traits and major reasons for treatment failure. Delineation of invasive growth is important in establishing treatment for gliomas and experimental neuro-oncology could benefit from an invasive glioma model. In this study, we established two new cell line-based animal models of invasive glioma.
METHODS: Two cell lines, J3T-1 and J3T-2, were derived from the same parental canine glioma cell line, J3T. These cells were inoculated to establish brain tumors in athymic mice and rats. Pathologic samples of these animal gliomas were examined to analyze invasive patterns in relation to angiogenesis, and were compared with human glioblastoma samples. The molecular profiles of these cell lines were also shown.
RESULTS: Histologically, J3T-1 and J3T-2 tumors exhibited different invasive patterns. J3T-1 cells clustered around newly developed vessels at tumor borders, whereas J3T-2 cells showed diffuse single cell infiltration into surrounding healthy parenchyma. In human malignant glioma samples, both types of invasion were observed concomitantly. Molecular profiles of these cell lines were analyzed by immunocytochemistry and with quantitative reverse transcription polymerase chain reaction. Vascular endothelial growth factor, matrix metalloproteinase-9, hypoxia-inducible factor-1, and platelet-derived growth factor were overexpressed in J3T-1 cells rather than in J3T-2 cells, whereas integrin αvβ3, matrix metalloproteinase-2, nestin, and secreted protein acidic and rich in cysteine were overexpressed in J3T-2 cells rather than in J3T-1 cells.
CONCLUSIONS: These animal models histologically recapitulated two invasive and angiogenic phenotypes, namely angiogenesis-dependent and angiogenesis-independent invasion, also observed in human glioblastoma. These cell lines provided a reproducible in vitro and in vivo system to analyze the mechanisms of invasion and angiogenesis in glioma progression.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22120277     DOI: 10.1016/j.wneu.2011.09.005

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  15 in total

1.  Bimodal anti-glioma mechanisms of cilengitide demonstrated by novel invasive glioma models.

Authors:  Manabu Onishi; Tomotsugu Ichikawa; Kazuhiko Kurozumi; Kentaro Fujii; Koichi Yoshida; Satoshi Inoue; Hiroyuki Michiue; E Antonio Chiocca; Balveen Kaur; Isao Date
Journal:  Neuropathology       Date:  2012-09-19       Impact factor: 1.906

Review 2.  Dogs are man's best friend: in sickness and in health.

Authors:  R Timothy Bentley; Atique U Ahmed; Amy B Yanke; Aaron A Cohen-Gadol; Mahua Dey
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

3.  Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.

Authors:  Y Otani; T Ichikawa; K Kurozumi; S Inoue; J Ishida; T Oka; T Shimizu; Y Tomita; Y Hattori; A Uneda; Y Matsumoto; H Michiue; I Date
Journal:  Oncogene       Date:  2017-10-23       Impact factor: 9.867

4.  Proteomics-based analysis of invasion-related proteins in malignant gliomas.

Authors:  Tomoko Maruo; Tomotsugu Ichikawa; Hirotaka Kanzaki; Satoshi Inoue; Kazuhiko Kurozumi; Manabu Onishi; Koichi Yoshida; Hirokazu Kambara; Mamoru Ouchida; Kenji Shimizu; Seiji Tamaru; E Antonio Chiocca; Isao Date
Journal:  Neuropathology       Date:  2012-11-01       Impact factor: 1.906

Review 5.  Phenotypic Transition as a Survival Strategy of Glioma.

Authors:  Tomotsugu Ichikawa; Yoshihiro Otani; Kazuhiko Kurozumi; Isao Date
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-05-11       Impact factor: 1.742

6.  Antiangiogenic therapy for glioma.

Authors:  Valentina Cea; Carlo Sala; Chiara Verpelli
Journal:  J Signal Transduct       Date:  2012-07-08

Review 7.  Mechanisms of tumor development and anti-angiogenic therapy in glioblastoma multiforme.

Authors:  Manabu Onishi; Kazuhiko Kurozumi; Tomotsugu Ichikawa; Isao Date
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-10-25       Impact factor: 1.742

8.  Integrin inhibitor suppresses bevacizumab-induced glioma invasion.

Authors:  Joji Ishida; Manabu Onishi; Kazuhiko Kurozumi; Tomotsugu Ichikawa; Kentaro Fujii; Yosuke Shimazu; Tetsuo Oka; Isao Date
Journal:  Transl Oncol       Date:  2014-03-04       Impact factor: 4.243

Review 9.  Bevacizumab in Japanese patients with malignant glioma: from basic research to clinical trial.

Authors:  Shingo Takano; Eiichi Ishikawa; Kei Nakai; Masahide Matsuda; Tomohiko Masumoto; Tetsuya Yamamoto; Akira Matsumura
Journal:  Onco Targets Ther       Date:  2014-09-05       Impact factor: 4.147

10.  Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.

Authors:  Sébastien Bougnaud; Anna Golebiewska; Anaïs Oudin; Olivier Keunen; Patrick N Harter; Lisa Mäder; Francisco Azuaje; Sabrina Fritah; Daniel Stieber; Tony Kaoma; Laurent Vallar; Nicolaas H C Brons; Thomas Daubon; Hrvoje Miletic; Terje Sundstrøm; Christel Herold-Mende; Michel Mittelbronn; Rolf Bjerkvig; Simone P Niclou
Journal:  Oncotarget       Date:  2016-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.